zedie.wordpress.com
A First in Lung Cancer: Immunotherapy Improves Survival
The immune checkpoint inhibitor nivolumab (Opvido, Bristol-Myers Squibb), which was recently approved for use in melanoma, has shown a survival advantage over chemotherapy in a pivotal trial in lun…